In a complementary pharmacological approach, we used the HIF-1α-inhibitor 2-methoxy-estradiol (2ME2) to investigate its effect on the migratory and adhesive ability of gastric cancer cells. The gene discussed is HIF1A; the disease is gastric cancer.